Inovio Pharmaceuticals Inc

NASDAQ:INO   12:59:55 PM EDT
7.26
+0.34 (+4.91%)
Earnings Announcements

Inovio Posts Q3 Loss Per Share Of $0.29

Published: 11/09/2021 23:10 GMT
Inovio Pharmaceuticals Inc (INO) - Inovio Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.29.
Dosing for Innovate Phase 3 Segment is Underway and We Aim to Have Interim Efficacy Data in the First Half 2022.
Revenue is expected to be $2.3 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0.32 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.